MRNA 'Youth Protein' trial launches in healthy seniors
NCT ID NCT07544420
First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This early-stage study tests a new mRNA medicine (aKL003) designed to increase levels of a protein linked to healthy aging. About 21 healthy adults aged 50–90 will receive two injections of either the active drug or a placebo. The main goal is to check safety and how well the body tolerates the treatment, not to cure any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GARM
Roatán, Bay Islands, 34101, Honduras
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.